<?xml version='1.0' encoding='iso-8859-1'?>
<newsitem date="1997-02-03" id="root" itemid="351901" xml:lang="en">
<title>USA: Elan Corp Q3 loss $1.43 after charges.</title>
<headline>Elan Corp Q3 loss $1.43 after charges.</headline>
<dateline>NEW YORK 1997-02-03</dateline>
<text>
<p>1996		     1995</p>
<p> Shr loss	  $1.43	  profit  $0.31</p>
<p> Net loss	  144,179	profit  23,295</p>
<p> Revs		 84,620		  55,650</p>
<p> Avg shrs	  100,587		  75,980</p>
<p>	  9  MONTHS</p>
<p> Shr loss	  $6.07	  profit   $0.86</p>
<p> Net loss	  572,568	profit   62,309</p>
<p> Revs		235,559		  153,382</p>
<p> Avg shrs	   94,399		   72,824</p>
<p>(All data above 000s except per share numbers)</p>
<p>NOTES: Share and net income information are before charges.</p>
<p>One-time charges in 1996 quarter comprise principally write-off of acquired in-process research and development of $154.4 million related to Advanced Therapeutic Systems Ltd acquisition and $18.0 million from disposing medical nutrition business in current quarter. Company also incurred Q2 for write-off of acquired in-process research and development arising from Athena Neurosciences acquisition on July 1.</p>
<p>The share and per share numbers have been adjusted for the effect of a 2-for-1 stock split effected on August 22, 1996.</p>
<p>Elan changed its reporting currency effective April 1, 1996 from the Irish pound to the US dollar. Prior year amounts have been restated into US dollars at the average rate of exchange between the Irish pound and US dollar applicable during the period reported.</p>
</text>
<copyright>(c) Reuters Limited 1997</copyright>
<metadata>
<dc element="dc.date.created" value="1997-02-03" />
<dc element="dc.publisher" value="Reuters Holdings Plc" />
<dc element="dc.date.published" value="1997-02-03" />
<dc element="dc.source" value="Reuters" />
<dc element="dc.creator.location" value="NEW YORK" />
<dc element="dc.creator.location.country.name" value="USA" />
<dc element="dc.source" value="Reuters" />
</metadata>
</newsitem>